跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TOLANZ ODT TABLETS 5 MG - HSA Drug Approval Details
Approvals
/
HSA
/
TOLANZ ODT TABLETS 5 MG
Approved
THERAPEUTIC
TOLANZ ODT TABLETS 5 MG
TORRENT PHARMACEUTICALS LTD (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
May 26, 2017
Approval ID
dc2f9435d12c1a94
Company
TORRENT PHARMACEUTICALS LTD (INDIA)
Type
Therapeutic
Approval Details
Approval Id
dc2f9435d12c1a94
Drug Name
TOLANZ ODT TABLETS 5 MG
Product Name
TOLANZ ODT TABLETS 5 MG
Approval Number
SIN15246P
Approval Date
2017-05-26
Registrant
APOTHECA MARKETING PTE LTD
Licence Holder
APOTHECA MARKETING PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route Of Administration
ORAL
Atc Code
N05AH03
Atc Item Name
olanzapine
Pharma Manufacturer Name
APOTHECA MARKETING PTE LTD
Company Detail Path
/organization/apotheca-marketing-pte-ltd
Active Ingredients
Olanzapine
5 mg
OLANZAPINE
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 26, 2017
Approval ID
dc2f9435d12c1a94
Type
Therapeutic
Back to HSA Approvals